Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybridos dose-finding and diagnostic model validation study in women with hypoactive sexual desire disorder
2013-001966-40Phase 2Active
- Sponsor
- Companion Diagnostics
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sildenafil + testosterone and Lybridos in hypoactive sexual desire disorder (HSDD) and SSRI-induced sexual dysfunction (4 arms), sponsored by Companion Diagnostics. Primary endpoint: Number of satisfactory sexual episodes. Started Jun 2013; status: active.
02
Drugs
sildenafil + testosteroneLybridos
03
Conditions
hypoactive sexual desire disorder (HSDD)SSRI-induced sexual dysfunction
Beyond the preview
Go deeper on 2013-001966-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001966-40.